mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.03 |